Schrodinger, Inc.
$19.40
Stock Quotes & Analysis
SDGR3.24%
$19.40
Latest AAPL News (Need to figure out how to make this dynamic)
test
Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and…
The political winds are shifting, and Wall Street is taking notice. As Donald Trump’s approval…
In the shadows of Silicon Valley’s AI frenzy, a sleeping giant is awakening. While tech…
Schrodinger, Inc.Status: Active
Sector: Healthcare
Industry: Health Information Services
Symbol: SDGR
Exchange: NMS
Employees: 891
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
 | 1540 Broadway, New York, NY, United States |
 | 212 295 5800 |
 | https://www.schrodinger.com |